医疗器械行业
- (2019-12-24)
- (2019-12-24)
- (2019-12-24)
- (2019-12-24)
- (2019-12-24)
- (2019-12-24)
- (2019-12-23)
- (2019-12-23)
- (2019-12-23)
- (2019-12-23)
- (2019-12-23)
- (2019-12-23)
Enhertu (trastuzumab deruxtecan)在美国获批用于治疗此前接受过两次或两次以上抗HER2疗法的HER2阳性不可切除或转移性乳腺癌患者
(2019-12-23)- (2019-12-22)
- (2019-12-22)
- (2019-12-22)
- (2019-12-22)
- (2019-12-22)
- (2019-12-22)
- (2019-12-22)
- (2019-12-22)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-21)
- (2019-12-20)
- (2019-12-20)
- (2019-12-20)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-19)
- (2019-12-18)
- (2019-12-18)
- (2019-12-17)
- (2019-12-16)
- (2019-12-16)
- (2019-12-16)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-15)
- (2019-12-14)
- (2019-12-14)
- (2019-12-14)
- (2019-12-14)
- (2019-12-14)
- (2019-12-14)
- (2019-12-14)
- (2019-12-14)
- (2019-12-14)
- (2019-12-13)